Discovery-stage molecular and proteomics characterisation platforms
Analytical and characterisation instruments bought by discovery-stage biotechnology and pharmaceutical companies, and by discovery research groups within contract research organisa
Intelligence / Healthtech & medtech market map / Life-science tools, instruments and laboratory services / Analytical and characterisation instruments
Instruments used to identify, measure, image or characterise molecules, cells, materials and biological processes, including mass spectrometry, chromatography, spectroscopy, microscopy and sequencing platforms.
Split by customer type.
Analytical and characterisation instruments bought by discovery-stage biotechnology and pharmaceutical companies, and by discovery research groups within contract research organisa
Analytical and characterisation instruments bought by pharmaceutical and biotechnology companies, and by contract research organisations serving them, to quantify drug candidates,
Analytical and characterisation instruments bought by pharmaceutical and biotechnology companies, contract development and manufacturing organisations, and contract research organi
Sequencing, imaging and single-cell analysis platforms bought by pharmaceutical and biotechnology companies, contract research organisations and academic research institutions to c
Named in public sources; linked to the source.
$65.9B ($62.5B–$70.0B) · 2026 · Proxy
Proxy from published life-science instrumentation markets: USD 65.92B in 2026 (Fortune Business Insights) and USD 70.02B in 2026 for life-science and chemical instrumentation (Mordor Intelligence); the midpoint is used. The 2034 forecast of USD 105.33B and 6.0% CAGR are from Fortune Business Insights. Instrumentation is a subset of the broader life-science tools market.
// Sell into Analytical and characterisation instruments